HEALSTORY

Serial Number 88932938
Registration 6624806
700

Registration Progress

Application Filed
May 26, 2020
Under Examination
Approved for Publication
Nov 9, 2021
Published for Opposition
Nov 9, 2021
Registered
Jan 25, 2022

Basic Information

Serial Number
88932938
Registration Number
6624806
Filing Date
May 26, 2020
Registration Date
January 25, 2022
Published for Opposition
November 9, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 25, 2022
Registration
Registered
Classes
005

Rights Holder

ICURE Pharmaceutical Inc.

03
Address
7F, 10, Bongeunsa-ro 104-gil, Gangnam-gu
Seoul 06170
KR

Ownership History

ICURE Pharmaceutical Inc.

Original Applicant
03
Seoul KR

ICURE Pharmaceutical Inc.

Owner at Publication
03
Seoul KR

ICURE Pharmaceutical Inc.

Original Registrant
03
Seoul KR

Legal Representation

Attorney
Jong H Park
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Dec 09, 2021 1306 days overdue Medium Until Jan 09, 2022

Application History

21 events
Date Code Type Description
Jan 25, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 PUBO A PUBLISHED FOR OPPOSITION
Nov 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2021 ALIE A ASSIGNED TO LIE
Aug 15, 2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 30, 2021 CNSL R SUSPENSION LETTER WRITTEN
Mar 30, 2021 GNSL S LETTER OF SUSPENSION E-MAILED
Mar 30, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 1, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2020 CNRT R NON-FINAL ACTION WRITTEN
Sep 1, 2020 GNRT F NON-FINAL ACTION E-MAILED
Sep 1, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2020 DOCK D ASSIGNED TO EXAMINER
Jun 12, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
nutraceutical preparations for use as a dietary supplement for therapeutic and or medical purposes; vitamins; mineral preparations for medical purposes; dietary supplements; food for diabetics in the nature of diabetic bread adapted for medical purposes; food supplements; milk powders for babies; food supplements for veterinary purposes; homogenized food adapted for medical purposes; freeze-dried food adapted for medical purposes; gluten-free foods adapted for medical purposes; medicated additives in the nature of dietary supplements for animal feeds; dietary and nutritionally fortified food products in the nature of supplements adapted for medical purposes; anti-oxidant food supplements; dietetic substances in the nature of dietetic foods and beverages for medical use consisting of vitamins, minerals, amino acids and trace elements; allergy medications; pharmaceutical agents affecting metabolism; pharmaceutical preparations for peripheral nervous system; pharmaceutical agents affecting digestive organs
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005